BUZZ-Aurinia Pharma drops on plans of private placement
** Drug developer's U.S-listed shares down 15 pct at $2.90, set for their worst day in a year
** Aurinia plans private placement on unspecified number of units at $2.36/unit and it has received commitments to purchase totaling $7.1 mln
** Each unit to consist of one common share plus 0.35 share purchase warrant
** The company had about 32 mln shares outstanding as of September 2015
** Up to Tuesday's close, stock had fallen about 15 pct this year (RM: firstname.lastname@example.org)
© Thomson Reuters 2017 All rights reserved.